Appraising the literature - PowerPoint PPT Presentation

1 / 55
About This Presentation
Title:

Appraising the literature

Description:

... other evidence. Journals. Text books. one stop shop for ... Text books. one stop shop for information ... exposure to A2 milk causes insulin dependent diabetes ... – PowerPoint PPT presentation

Number of Views:32
Avg rating:3.0/5.0
Slides: 56
Provided by: Mar5541
Category:

less

Transcript and Presenter's Notes

Title: Appraising the literature


1
Appraising the literature
  • Mark Stevenson
  • EpiCentre, IVABS, Massey University, Palmerston
    North
  • M.Stevenson_at_massey.ac.nz

2
Roadmap
  • Journals
  • Appraising the literature
  • description of the evidence
  • internal validity
  • external validity
  • comparison of the results with other evidence

3
Journals
  • Text books
  • one stop shop for information
  • represent the opinion of one or a small number of
    authors
  • out of date by the time they are published
  • Journals
  • articles deal with a single subject (in detail)
  • up to date
  • peer reviewed

4
Journals
  • Text books
  • one stop shop for information
  • represent the opinion of one or a small number of
    authors
  • out of date by the time they are published
  • Journals
  • articles deal with a single subject (in detail)
  • up to date
  • peer reviewed

5
(No Transcript)
6
Journals
  • A citation
  • Bates T, Thurmond M, Hietala S, et al. (2003)
    Surveillance for detection of foot-and-mouth
    disease. Journal of the American Veterinary
    Medical Association 223, 609 - 614.

7
Journals
  • A citation
  • Bates T, Thurmond M, Hietala S, et al. (2003)
    Surveillance for detection of foot-and-mouth
    disease. Journal of the American Veterinary
    Medical Association 223, 609 - 614.
  • who wrote the article
  • et al. is latin for et alia which means and
    others

8
Journals
  • A citation
  • Bates T, Thurmond M, Hietala S, et al. (2003)
    Surveillance for detection of foot-and-mouth
    disease. Journal of the American Veterinary
    Medical Association 223, 609 - 614.
  • the year the article was published

9
Journals
  • A citation
  • Bates T, Thurmond M, Hietala S, et al. (2003)
    Surveillance for detection of foot-and-mouth
    disease. Journal of the American Veterinary
    Medical Association 223, 609 - 614.
  • the title of the article

10
Journals
  • A citation
  • Bates T, Thurmond M, Hietala S, et al. (2003)
    Surveillance for detection of foot-and-mouth
    disease. Journal of the American Veterinary
    Medical Association 223, 609 - 614.
  • the journal in which the article was published
  • frequently abbreviated (e.g. JAVMA)

11
Journals
  • A citation
  • Bates T, Thurmond M, Hietala S, et al. (2003)
    Surveillance for detection of foot-and-mouth
    disease. Journal of the American Veterinary
    Medical Association 223, 609 - 614.
  • the volume in which the article appeared

12
Journals
  • A citation
  • Bates T, Thurmond M, Hietala S, et al. (2003)
    Surveillance for detection of foot-and-mouth
    disease. Journal of the American Veterinary
    Medical Association 223, 609 - 614.
  • the page numbers

13
Journals
  • In the olden days
  • travel to the library
  • photocopy the articles youre interested in
  • These days
  • on-line access to journal material
  • articles distributed in PDF (portable document
    format)
  • on-line library access for Massey graduates?
  • University of Sydney VEIN

14
(No Transcript)
15
(No Transcript)
16
(No Transcript)
17
(No Transcript)
18
(No Transcript)
19
Journals
  • Advantages
  • remote access
  • searchable
  • saves paper
  • portable
  • Disadvantages
  • just not the same as flicking through a journal

20
Journals
  • Internet
  • facilitated the dissemination of information
  • varying quality
  • As good scientists, we need to be discerning
    about what we read and (more importantly) what we
    believe
  • A systematic method of appraising (or evaluating)
    the literature helps us to do this

21
Roadmap
  • Journals
  • Appraising the literature
  • description of the evidence
  • internal validity
  • external validity
  • comparison of the results with other evidence

22
Roadmap
  • Journals
  • Appraising the literature
  • description of the evidence
  • internal validity
  • external validity
  • comparison of the results with other evidence

23
Description of the evidence
  • What hypothesis was being tested?
  • What was the study design?
  • survey
  • clinical trial
  • case-control study
  • prospective or retrospective cohort study
  • cross sectional study
  • What were the exposure variable(s) and what was
    the outcome variable?

24
Randomised clinical trial
25
Cross sectional study
26
Description of the evidence
  • Definition of the subjects that were studied in
    terms of
  • source populations
  • time frames
  • eligibility criteria
  • participation rates of the different groups
    compared
  • Summary of the main result
  • what is the result of the study in terms of the
    relationship between exposure and outcome?

27
Roadmap
  • Journals
  • Appraising the literature
  • description of the evidence
  • internal validity
  • external validity
  • comparison of the results with other evidence

28
Internal validity
  • Internal validity
  • describes the truthfulness of inferences about
    the study population (i.e. those that took part
    in the study)
  • how well was the study done?
  • often, researchers claim that exposure to one
    factor causes a specific outcome
  • exposure to A2 milk causes insulin dependent
    diabetes
  • we need to evaluate these claims very carefully
  • differentiate between causation and association

29
Age adjusted mortality rates as a function of
particulate air matter concentration for 100
capital cities throughout the world.
30
Internal validity
  • Two aspects of internal validity
  • non-causal explanations
  • positive features of causation

31
Internal validity
  • Three possible non-causal mechanisms which could
    produce the observed results
  • bias errors in measurement
  • confounding more next year
  • chance variation did they fluke it?

32
Internal validity
  • Bias
  • bias in ascertainment
  • surveillance, diagnosis, referral, selection,
    non-response, length of stay, survival bias
  • bias in the estimation of exposure
  • recall, interviewer, prevarification, improper
    analysis

33
Internal validity
  • Confounding
  • refers to the effect of an extraneous variable
    that wholly or partially accounts for the
    apparent effect of the study exposure, or masks
    an underlying true association
  • ???
  • best explained by an example

34
Internal validity
  • Confounding (cont.)
  • ? use of oral contraceptives ? risk of myocardial
    infarction (MI)
  • ? smoking ? risk of myocardial infarction
  • there is evidence to show that women who use oral
    contraceptives are more likely to smoke more than
    women who do not
  • if we conduct a study and find a positive
    relationship between oral contraceptive use and
    MI, we need to be careful that we have accounted
    for the confounding influence of smoking, before
    making a claim that a causal relationship between
    oral contraceptives and MI exists

35
Internal validity
  • Chance
  • was a relationship between exposure and outcome
    identified by chance?
  • if we perform 20 statistical tests using an alpha
    level of 0.05, we will make a type I error on one
    occasion
  • what is a type I error?
  • you reject the null hypothesis when, in reality,
    it is true

36
Internal validity
  • The order of these non-causal explanations is
    important
  • if there is severe bias, no analytical
    manipulation of the data will overcome the
    problem
  • if there is confounding, then appropriate
    analysis will (in most cases) overcome the
    problem
  • assessment of chance variation should be made on
    the main result of the study, after considering
    issues of bias and confounding

37
Internal validity
  • Three aspects of positive features of causation
    should be considered
  • 1. Is there a correct temporal relationship?
  • 2. Is the relationship strong?
  • 3. Is there a dose-response relationship?

38
Internal validity
  • Is there a correct temporal relationship?
  • for a relationship to be causal, the exposure
    must act before the outcome occurs
  • in a prospective study design this requirement is
    established by ensuring that subjects do not
    already have the outcome of interest when the
    study starts
  • the ability to clarify time relationships is
    weaker in retrospective studies, and care is
    required to ensure that possible causal factors
    did in fact occur before the outcome of interest

39
Internal validity
  • Is there a correct temporal relationship (cont.)?
  • a difficulty in all study designs, but more so in
    retrospective studies, is that the occurrence in
    biological terms of the outcome of interest may
    precede the recognition and documentation of that
    outcome by a long and variable period of time
    (e.g. some cancers)

40
Internal validity
  • Is the relationship strong?
  • a stronger measure of association is more likely
    to indicate a causal relationship
  • the fact that a relationship is strong does not
    protect us against certain non-causal
    relationships, however if the relationship that
    is observed is due to bias, then the bias must be
    large and therefore easily identified
  • if a strong relationship is due to confounding,
    either the association of the exposure with the
    confounder must be very close, or the association
    of the confounder with the outcome must be very
    strong

41
Internal validity
  • Is there a dose-response relationship?
  • in some circumstances the demonstration of a
    smooth dose-response relationship may be a strong
    argument against an identified relationship
    arising as a result of bias
  • in general, we should expect uni-directional
    dose-effect relationships and evidence that this
    is not the case should be considered carefully

42
Roadmap
  • Journals
  • Appraising the literature
  • description of the evidence
  • internal validity
  • external validity
  • comparison of the results with other evidence

43
External validity
  • External validity ? generalisability of the
    results
  • if the internal validity of a study is poor, then
    there is no point in proceeding further
  • Three aspects of external validity should be
    considered
  • 1. Can the results be applied to the eligible
    population?
  • 2. Can the results be applied to the source
    population?
  • 3. Can the results be applied to other relevant
    populations?

44
External validity
  • Can the results be applied to the eligible
    population?
  • the relationship between the study participants
    (those that participated in the study) and the
    population of eligible subjects (those that met
    the study inclusion criteria but did not take
    part) should be well documented
  • losses due to non-participation have to be
    considered carefully as they are likely to be
    non-random, and the reasons for the losses may be
    related to the exposure or the outcome

45
External validity
  • Can the results be applied to the source
    population?
  • the important issue is not whether the subjects
    studied are 'typical', but whether the
    association between outcome and exposure given by
    the study participants is likely to apply to
    other groups

46
External validity
  • Can the results be applied to other relevant
    populations?
  • in general, the difficulties of applying results
    from one groups of subjects to another will be
    minimal for issues of basic physiology and
    maximal for effects in which cultural and
    psycho-social aspects are dominant

47
Roadmap
  • Journals
  • Appraising the literature
  • description of the evidence
  • internal validity
  • external validity
  • comparison of the results with other evidence

48
Comparison with other evidence
  • Clinical questions
  • useful to consider a hierarchy of evidence
  • given that studies are adequately performed
    within the limitations of the design used, the
    reliability of the information from them can be
    ranked as follows
  • randomised trials
  • cohort and case-control studies
  • other comparative studies
  • case series, descriptive studies, clinical
    experience

49
Comparison with other evidence
  • Clinical questions
  • randomised clinical trials, if properly performed
    on adequate numbers of subjects, provide greatest
    evidence because of the unique advantages in
    overcoming problems of bias and confounding
  • Three aspects of comparison should be considered
  • 1. Are the results consistent with other
    evidence?
  • 2. Are the results plausible biologically?
  • 3. Is there coherency with the distribution of
    the exposure and the outcome?

50
Comparison with other evidence
  • Are the results consistent with other evidence?
  • this is the most important characteristic used in
    the judgement that an association is causal
  • to say that the result is consistent requires
    that the association has been observed in a
    number of different studies, each of which
    individually can be interpreted as showing a
    causal explanation, and which have enough
    variation in their methodology and study
    populations to make it unlikely that the same
    biases or confounding factors apply in all the
    studies
  • lack of consistency argues against causality

51
Relative risks (and their 95 confidence
interval) from six trials comparing the effect of
CIDR treatment with untreated controls on
submission rate.
Meta-analysis
52
Relative risks (and their 95 confidence
interval) from 12 trials comparing the effect of
post insemination CIDR treatment with untreated
controls on conception rate.
53
Comparison with other evidence
  • Are the results plausible biologically?
  • plausibility refers to the observed association
    being biologically understandable on the basis of
    current knowledge concerning its likely
    mechanisms
  • however, any dramatically new observation may be
    in advance of current biological thinking and its
    lack of plausibility may reflect deficiencies in
    biological knowledge rather than error in
    observation
  • John Snow effectively prevented cholera in London
    25 years before the isolation of the cholera
    bacillus and the general acceptance of the
    principle that the disease could be spread by
    water

54
Comparison with other evidence
  • Coherency with the distribution of the exposure
    and the outcome?
  • an association is regarded as coherent if it fits
    the general features of the distribution of both
    the exposure and the outcome under assessment
  • if lung cancer is due to smoking, the frequency
    of lung cancer in different populations and in
    different time periods should relate to the
    frequency of smoking in those populations at
    earlier relevant time periods

55
Summary
What are they on about?
  • Description of the evidence
  • type of study, outcome measure, population
    investigated, results
  • Internal validity

Did they do things properly?
  • non-causal explanations
  • bias
  • confounding
  • chance
  • positive features of causation
  • temporal relationship
  • strength of relationship
  • dose-response

56
Summary
Can we apply these results to other populations?
  • External validity
  • can the results be applied to the eligible
    population?
  • can the results be applied to the source
    population?
  • can the results be applied to other relevant
    populations?
  • Comparison of the results with other evidence
  • are the results consistent with other evidence?
  • are the results plausible biologically?
  • is there coherency with the distribution of the
    exposure and the outcome?

Are the findings reported here consistent with
other studies that looked at the same thing?
57
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com